Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

401 recalls · Class II, newest first

Class II · Moderate risk

Lidocaine HCl Injection

Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.

Terminated Particulate / foreign matter Hospira, Inc. NDC 0409-4279-02 D-099-2013
Class II · Moderate risk

Moexipril HCl Tablets 7.5mg

Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.

Terminated Dissolution failure Paddock Laboratories, LLC NDC 0574-0110-01 D-007-2013
Class II · Moderate risk

Dr. Reddy's Quetiapine Fumarate Tablets

Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 55111-249-05 D-059-2013
Class II · Moderate risk

Lactated Ringer's Injection USP

Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).

Terminated Chemical / undeclared Baxter Healthcare Corp. NDC 0338-6307-02 D-1690-2012
Class II · Moderate risk

0.9% Sodium Chloride Injection USP

Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).

Terminated Chemical / undeclared Baxter Healthcare Corp. NDC 0338-6304-02 D-1689-2012
Class II · Moderate risk

10% Dextrose Injection USP

Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).

Terminated Chemical / undeclared Baxter Healthcare Corp. NDC 0338-6347-03 D-1687-2012
Class II · Moderate risk

5% Dextrose Injection USP

Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).

Terminated Chemical / undeclared Baxter Healthcare Corp. NDC 0338-6346-02 D-1686-2012
Class II · Moderate risk

Limed Bone Gelatin

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination American Enterprises LLC dba Sterling Gelatin D-062-2013

Recalls by year